MA Robin
Impact in
- Pharmacology top 2%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment
- Cytomegalovirus and herpesvirus research
Papers in
-
- Liver Disease Diagnosis and Treatment 4
- Cytomegalovirus and herpesvirus research 1
-
- Lipid metabolism and biosynthesis 1
- Co-authors
- Bernard Fromenty (6 shared papers)Dominique Pessayre (5 shared papers)Abdellah Mansouri (1 shared paper)Karima Begriche (1 shared paper)Anissa Igoudjil (1 shared paper)Laetitia Knockaert (1 shared paper)J. Aubert (1 shared paper)Philippe Lettéron (4 shared papers)
- Journals
- Gastroenterology (2 papers)American Journal of Physiology-Gastrointestinal and Liver Physiology (1 paper)British Journal of Pharmacology (1 paper)Journal of Hepatology (1 paper)Journal of Antimicrobial Chemotherapy (1 paper)
- Partner nations
- France
In The Last Decade
MA Robin
8 papers receiving 808 citations
Peers
Comparison fields: 5 of 66
- Pharmacology 213
- Epidemiology 446
- Hepatology 34
- Biochemistry 20
- Biochemistry 15
Countries citing papers authored by MA Robin
This map shows the geographic impact of MA Robin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MA Robin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MA Robin more than expected).
Fields of papers citing papers by MA Robin
This network shows the impact of papers produced by MA Robin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MA Robin. The network helps show where MA Robin may publish in the future.
Co-authors
The 20 scholars most cited alongside MA Robin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 240 | |
| 2 | 2004 | 238 | |
| 3 | 2010 | 134 | |
| 4 | 1997 | 95 | |
| 5 | 1996 | 63 | |
| 6 | 1996 | 33 | |
| 7 | 2011 | 32 | |
| 8 | 2006 | 2 |
About MA Robin
MA Robin is a scholar working on Epidemiology, Biochemistry, Pharmacology, Cancer Research and Pathology and Forensic Medicine, having authored 8 papers that have together received 837 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (4 papers), Drug-Induced Hepatotoxicity and Protection (1 paper), Lipid metabolism and biosynthesis (1 paper), Cancer, Lipids, and Metabolism (1 paper), Cytomegalovirus and herpesvirus research (1 paper), Alcohol Consumption and Health Effects (1 paper) and Nitric Oxide and Endothelin Effects (1 paper). The work is most often cited by research in Pharmacology (213 citations), Epidemiology (446 citations), Hepatology (34 citations), Biochemistry (20 citations) and Biochemistry (15 citations). MA Robin has collaborated with scholars based in France. Frequent co-authors include Bernard Fromenty, Dominique Pessayre, Abdellah Mansouri, Karima Begriche, Anissa Igoudjil, Laetitia Knockaert, J. Aubert, Philippe Lettéron, Gérard Feldmann and Alain Berson. Their work appears in journals such as Gastroenterology, American Journal of Physiology-Gastrointestinal and Liver Physiology, British Journal of Pharmacology, Journal of Hepatology and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.